生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | SH-4-54 demonstrates remarkable effectiveness in killing glioblastoma brain cancer stem cells (BTSCs) by strongly inhibiting STAT3 phosphorylation and its downstream transcriptional activities at low nanomolar concentrations. Exhibiting significant cytotoxicity against human BTSCs while sparing human fetal astrocytes, SH-4-54 effectively inhibits pSTAT3 with nanomolar IC50s, showing specific action without detectable off-target effects at therapeutic levels[1]. |
细胞研究 | |||||
---|---|---|---|---|---|
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
human 127EF cells | Cytotoxic assay | 3 days | Cytotoxicity against human 127EF cells assessed as cell viability after 3 days by Alamar Blue assay, IC50=66 nM | 24900612 | |
human 147EF cells | Function assay | 2-72 h | Inhibition of STAT3 in human 147EF cells assessed as reduction of phosphorylated cyclin D1 level after 2 to 72 hrs by Western blotting analysis | 24900612 | |
human 25EF cells | Cytotoxic assay | 3 days | Cytotoxicity against human 25EF cells assessed as cell viability after 3 days by Alamar Blue assay, IC50=0.234 μM | 24900612 |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.64mL 0.33mL 0.16mL |
8.19mL 1.64mL 0.82mL |
16.38mL 3.28mL 1.64mL |
参考文献 |
---|